Eupraxia Pharmaceuticals' Unattributed - IV Round

Eupraxia Pharmaceuticals raised a round of funding on September 16, 2013.

Eupraxia Pharmaceuticals is a clinical stage pharmaceutical company targeting the most prevalent diseases in the western world. The company builds next-generation drugs that increase efficacy, duratio…

Articles about Eupraxia Pharmaceuticals' Unattributed - IV Round: